James T. Treace, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 330,986 shares at $16.12 ($957K) on 2021-12-21, disclosed to the SEC on 2021-12-22.
Open-market sale of $957k TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 270,789 | $0 | 0.0% |
| 2 | $15.69 | 15,719 | $247K | 25.8% |
| 3 | $15.69 | 15,719 | $247K | 25.8% |
| 4 | $16.30 | 400 | $7K | 0.7% |
| 5 | $16.12 | 13,478 | $217K | 22.7% |
| 6 | $16.12 | 13,478 |
| $217K |
| 22.7% |
| 7 | $16.36 | 1,403 | $23K | 2.4% |
| Total | $2.89 avg | 330,986 | $957K | 100% |
| Filing → |
| TMCI | BUY | 2024-05-30 | $130K | — | Filing → |
| TMCI | BUY | 2024-05-29 | $254K | — | Filing → |
| TMCI | BUY | 2024-05-13 | $1.0M | — | Filing → |